Biogen
BIIB
BIIB
1,009 hedge funds and large institutions have $37.6B invested in Biogen in 2019 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 316 increasing their positions, 451 reducing their positions, and 142 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,009
Holders Change
-74
Holders Change %
-6.83%
% of All Funds
21.95%
Holding in Top 10
16
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-27.27%
% of All Funds
0.35%
New
84
Increased
316
Reduced
451
Closed
142
Calls
$883M
Puts
$1.2B
Net Calls
-$319M
Net Calls Change
-$187M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
$602M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
$308M |
| 3 |
Renaissance Technologies
New York
|
$581M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
$583M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
$367M |
